4//SEC Filing
Mulligan Seamus 4
Accession 0001765581-23-000010
CIK 0001232524other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 8:30 PM ET
Size
6.7 KB
Accession
0001765581-23-000010
Insider Transaction Report
Form 4
Mulligan Seamus
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2023-03-04$59.13/sh+4,500$266,085→ 1,164,800 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2023-03-04−4,500→ 0 totalExercise: $59.13Exp: 2023-03-04→ Ordinary Shares (4,500 underlying)
Footnotes (1)
- [F1]The option was granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Option Plan and vested in 12 monthly installments over one year from the grant date, March 5, 2013.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001536639
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 8:30 PM ET
- Size
- 6.7 KB